Puromycin Dihydrochloride
Puromycin Dihydrochloride
Gibco™

Puromycin Dihydrochloride

Puromycin Dihydrochloride는 Streptomyces alboniger에서 만든 aminonucleoside 항생제입니다. 이는 진핵세포와 원핵세포 모두에서 peptidyl 전달을 억제합니다. 또한 이 항생제는 그램 양성 박테리아와자세히 알아보기
Have Questions?
보기 방식 변경buttonViewtableView
카탈로그 번호수량
A111380310 x 1 mL
A111380220 mL
카탈로그 번호 A1113803
제품 가격(KRW)
515,000
온라인 행사
Ends: 31-Dec-2025
542,000
할인액 27,000 (5%)
Each
카트에 추가하기
수량:
10 x 1 mL
제품 가격(KRW)
515,000
온라인 행사
Ends: 31-Dec-2025
542,000
할인액 27,000 (5%)
Each
카트에 추가하기
Puromycin Dihydrochloride는 Streptomyces alboniger에서 만든 aminonucleoside 항생제입니다. 이는 진핵세포와 원핵세포 모두에서 peptidyl 전달을 억제합니다. 또한 이 항생제는 그램 양성 박테리아와 다양한 동물 및 곤충 세포 성장을 억제합니다. Puromycin의 내성은 “pac” 유전자 발현으로 확인합니다. 이는 세포 생물학에서 포유류 및 줄기세포 배양 시스템의 선택제로 널리 사용됩니다.

Puromycin은 -20°C에 보관 시 용액 상태로 1년 간 안정합니다. 권장 용량은 10-100 μg⁄ml입니다. 단 원핵세포에는 1 μg⁄ml 농도에서 독성이 있을 수 있습니다. 이는 신속하게 작용하여 2일 내에 비내성 세포를 최대 99% 없앨 수 있습니다. 실험 수행 시 용량-반응 곡선을 만들어 숙주 cell line을 죽이는 데 필요한 항생제 최적 농도를 확인하도록 권장합니다.

화학식: C22H29N7O5, 2HCl 화학식량: 544.3 g⁄mole. 제형: 액체 용액 (멸균 여과), 10mg⁄mL용량: 10 x 1mL

본 제품은 냉장/냉동제품으로 반송된 제품은 전량 폐기 처리 되오니 주문 전 상세 내용 다시 한번 확인 부탁드립니다.
For Research Use Only. Not for use in diagnostic procedures.
사양
농도10 mg/mL
배양 유형Mammalian Cell Culture, Insect Cell Culture
용도(애플리케이션)Eukaryotic Selection⁄Stable Cell Line Generation
제품라인Gibco
수량10 x 1 mL
유통 기한12 Months
배송 조건Dry Ice
형태Liquid
제품 유형Antibiotic
멸균Sterile-filtered
첨가제 포함HEPES
Unit SizeEach
구성 및 보관
Storage conditions: -5 to -20°C
Shipping conditions: Frozen
Shelf life: 12 months from date of manufacture

자주 묻는 질문(FAQ)

Which of your antibiotics (Geneticin, Zeocin, Hygromycin B, Blasticidin, and Puromycin) can be used together for stable selection in mammalian cells?

All of our antibiotics (Geneticin, Zeocin, Hygromycin B, Blasticidin, and Puromycin) can be used together for making multiple stable cell lines. However, kill curves will need to be performed for each combination of antibiotics since sensitivity to a given antibiotic tends to increase when combined with other antibiotics.

How light-sensitive is Puromycin Dihydrochloride?

Puromycin Dihydrochloride is light sensitive on par with the light sensitivity of most basal media like DMEM and RPMI 1640. We would recommend limiting exposure of this product to light as much as possible (i.e,. don't leave on the bench or under hood lights longer than necessary). That said, using a light microscope to observe cells under normal conditions and timeframes will not break down the antibiotic.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

How can I decontaminate my cultures?

When an irreplaceable culture becomes contaminated, researchers may attempt to eliminate or control the contamination.

1. Determine if the contamination is bacteria, fungus, mycoplasma, or yeast. Read more here to view characteristics of each contaminant.
2. Isolate the contaminated culture from other cell lines.
3. Clean incubators and laminar flow hoods with a laboratory disinfectant, and check HEPA filters.
4. Antibiotics and antimycotics at high concentrations can be toxic to some cell lines. Therefore, perform a dose-response test to determine the level at which an antibiotic or antimycotic becomes toxic. This is particularly important when using an antimycotic such as Gibco Fungizone reagent or an antibiotic such as tylosin.

The following is a suggested procedure for determining toxicity levels and decontaminating cultures:

1. Dissociate, count, and dilute the cells in antibiotic-free media. Dilute the cells to the concentration used for regular cell passage.
2. Dispense the cell suspension into a multiwell culture plate or several small flasks. Add the antibiotic of choice to each well in a range of concentrations. For example, we suggest the following concentrations for Gibco Fungizone reagent: 0.25, 0.50, 1.0, 2.0, 4.0, and 8.0 µg/mL.
3. Observe the cells daily for signs of toxicity such as sloughing, appearance of vacuoles, decrease in confluency, and rounding.
4. When the toxic antibiotic level has been determined, culture the cells for two to three passages using the antibiotic at a concentration one- to two-fold lower than the toxic concentration.
5. Culture the cells for one passage in antibiotic-free media.
6. Repeat step 4.
7. Culture the cells in antibiotic-free medium for four to six passages to determine if the contamination has been eliminated.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What antibiotics do you offer to help control or eliminate cell culture contamination?

Please view the following page to browse the cell culture antibiotics we offer (https://www.thermofisher.com/us/en/home/life-science/cell-culture/mammalian-cell-culture/antibiotics.html).

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

인용 및 참조 문헌 (9)

인용 및 참조 문헌
Abstract
Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells.
Authors:Kuai X, Jia L, Yang T, Huang X, Zhao W, Zhang M, Chen Y, Zhu J, Feng Z, Tang Q
Journal:Med Sci Monit
PubMed ID:31964857
'BACKGROUND Chemotherapy is widely used in gastric cancer treatment, but multidrug resistance remains a leading cause of chemotherapy failure. Trop2 is highly expressed in gastric tumor tissues and greatly influences cancer progression. However, little is known about the relationship between Trop2 and drug resistance in gastric cancer. MATERIAL AND METHODS ... More
mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer.
Authors:Chiang CT, Demetriou AN, Ung N, Choudhury N, Ghaffarian K, Ruderman DL, Mumenthaler SM
Journal:Cancer Lett
PubMed ID:30036610
Non-small cell lung cancer (NSCLC) patients with activating EGFR mutations are often successfully treated with EGFR tyrosine kinase inhibitor (TKI) such as erlotinib; however, treatment resistance inevitably occurs. Given tumor metabolism of glucose and therapeutic response are intimately linked, we explored the metabolic differences between isogenic erlotinib-sensitive and -resistant NSCLC ... More
The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials.
Authors:Sheridan CM, Garcia VE, Ahyong V, DeRisi JL
Journal:Malar J
PubMed ID:30541569
The continued spectre of resistance to existing anti-malarials necessitates the pursuit of novel targets and mechanisms of action for drug development. One class of promising targets consists of the 80S ribosome and its associated components comprising the parasite translational apparatus. Development of translation-targeting therapeutics requires a greater understanding of protein ... More
Cardiac glycosides decrease influenza virus replication by inhibiting cell protein translational machinery.
Authors:Amarelle L, Katzen J, Shigemura M, Welch LC, Cajigas H, Peteranderl C, Celli D, Herold S, Lecuona E, Sznajder JI
Journal:Am J Physiol Lung Cell Mol Physiol
PubMed ID:30892074
Cardiac glycosides (CGs) are used primarily for cardiac failure and have been reported to have other effects, including inhibition of viral replication. Here we set out to study mechanisms by which CGs as inhibitors of the Na-K-ATPase decrease influenza A virus (IAV) replication in the lungs. We found that CGs ... More
Modulating eIF6 levels unveils the role of translation in ecdysone biosynthesis during Drosophila development.
Authors:Russo A, Gatti G, Alfieri R, Pesce E, Soanes K, Ricciardi S, Mancino M, Cheroni C, Vaccari T, Biffo S, Calamita P
Journal:Dev Biol
PubMed ID:31283922
During development, ribosome biogenesis and translation reach peak activities, due to impetuous cell proliferation. Current models predict that protein synthesis elevation is controlled by transcription factors and signalling pathways. Developmental models addressing translation factors overexpression effects are lacking. Eukaryotic Initiation Factor 6 (eIF6) is necessary for ribosome biogenesis and efficient ... More